Tattooing improves the detection of small lymph nodes and increases the number of retrieved lymph nodes in patients with rectal cancer who receive preoperative chemoradiotherapy: A randomized controlled clinical trial

Am J Surg. 2018 Apr;215(4):563-569. doi: 10.1016/j.amjsurg.2017.06.030. Epub 2017 Jul 6.

Abstract

Background: In rectal cancer who received chemoradiotherapy, the number of Lymph nodes (LNs) required remains unclear. We conducted a randomized controlled trial to determine whether preoperative tattooing increases the number of LNs and enhances the detection rate of metastatic LNs.

Methods: Eighty patients with rectal cancer who received chemoradiotherapy were randomly assigned to receive no tattooing (C group) or to receive tattooing (T group).

Results: The number of LNs was significantly higher in the T group (13.3 ± 7.4, mean ± SD) than in the C group (8.8 ± 5.9, p < 0.001), however, the number of positive LNs did not differ (0.5 ± 1.3 vs. 0.5 ± 1.1, p = 0.882). The long-axis diameter of LNs was significantly smaller in the T group than in the C group (3.4 ± 1.8 vs. 3.9 ± 2.3 mm, p < 0.001), however, the long-axis diameter of positive LNs did not differ.

Conclusions: Tattooing increased the number of retrieved LNs by 51%, however, there was no increase in the number of positive LNs.

Keywords: Chemoradiotherapy; Lymph node; Rectal cancer; Tattooing.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Chemoradiotherapy*
  • Combined Modality Therapy
  • Female
  • Humans
  • Lymph Node Excision*
  • Lymphatic Metastasis / pathology*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Preoperative Care*
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / surgery
  • Rectal Neoplasms / therapy*
  • Tattooing*
  • Treatment Outcome